Cello Health plc, together with its subsidiaries, provides marketing services in the United Kingdom, Rest of Europe, the United States, and internationally. It operates in two segments, Cello Health and Cello Signal. The Cello Health segment offers market research, consulting, and communications services principally to the pharmaceutical and healthcare clients.
Read More…
Industry, Sector and Symbol
Industry Marketing Services
Sub-IndustryN/A
SectorServices
CIKN/A
Phone+44-20-78128460
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales£167.91 million
Profitability
Miscellaneous
EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable
Cello Health (LON:CLL) Frequently Asked Questions
What is Cello Health's stock symbol?
Cello Health trades on the London Stock Exchange (LON) under the ticker symbol "CLL."
How often does Cello Health pay dividends? What is the dividend yield for Cello Health?
Cello Health declared a dividend on Wednesday, September 18th. Shareholders of record on Thursday, October 3rd will be paid a dividend of GBX 1.15 per share on Friday, November 1st. This represents a yield of 0.91%. The ex-dividend date of this dividend is Thursday, October 3rd. The official announcement can be viewed at this link. View Cello Health's Dividend History.
What price target have analysts set for CLL?
1 analysts have issued 1 year target prices for Cello Health's stock. Their forecasts range from GBX 135 to GBX 160. On average, they anticipate Cello Health's stock price to reach GBX 147.50 in the next year. This suggests a possible upside of 14.3% from the stock's current price. View Analyst Price Targets for Cello Health.
What is the consensus analysts' recommendation for Cello Health?
1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cello Health in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Cello Health.
Has Cello Health been receiving favorable news coverage?
News stories about CLL stock have been trending somewhat negative on Sunday, InfoTrie reports. The research group identifies negative and positive news coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Cello Health earned a media sentiment score of -1.0 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the company's share price in the near future. View News Stories for Cello Health.
Who are some of Cello Health's key competitors?
Some companies that are related to Cello Health include QMS Media (QMS), IVE Group (IGL), Wellcom Group (WLL), Tremor International (TRMR), GTN (GTN), Taptica International (TAP), cbdMD (YCBD), Salmat (SLM), Trimantium Growthops (TGO), NAHL Group (NAH), I Synergy Group (IS3), Ebiquity (EBQ), Arena Events Group (ARE), System1 Group (SYS1) and Tech Mpire (TMP).
What other stocks do shareholders of Cello Health own?
Who are Cello Health's key executives?
Cello Health's management team includes the folowing people:
- Mr. Mark Scott, CEO & Exec. Director (Age 53)
- Mr. Mark Bentley, Group Fin. Director, Company Sec. & Exec. Director (Age 48)
- Mr. Stephen Highley, Group COO & Director
- Mr. Owen Williams, Managing Partner
- Mr. Vincent Nolan, Managing Partner
How do I buy shares of Cello Health?
Shares of CLL and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is Cello Health's stock price today?
One share of CLL stock can currently be purchased for approximately GBX 129.
How big of a company is Cello Health?
What is Cello Health's official website?
How can I contact Cello Health?
Cello Health's mailing address is 11-13 Charterhouse Buildings, LONDON, EC1M 7AP, United Kingdom. The company can be reached via phone at +44-20-78128460.
MarketBeat Community Rating for Cello Health (LON CLL)
MarketBeat's community ratings are surveys of what our community members think about Cello Health and other stocks. Vote "Outperform" if you believe CLL will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CLL will underperform the S&P 500 over the long term. You may vote once every thirty days.
